Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 5
2004 4
2005 10
2006 7
2007 2
2008 4
2009 5
2010 7
2011 5
2012 5
2013 5
2014 6
2015 5
2016 6
2017 6
2018 3
2019 2
2020 4
2021 4
2022 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

92 results

Results by year

Filters applied: . Clear all
Page 1
The MexTAg collaborative cross: host genetics affects asbestos related disease latency, but has little influence once tumours develop.
Fisher SA, Patrick K, Hoang T, Marcq E, Behrouzfar K, Young S, Miller TJ, Robinson BWS, Bueno R, Nowak AK, Lesterhuis WJ, Morahan G, Lake RA. Fisher SA, et al. Among authors: robinson bws. Front Toxicol. 2024 Apr 17;6:1373003. doi: 10.3389/ftox.2024.1373003. eCollection 2024. Front Toxicol. 2024. PMID: 38694815 Free PMC article.
Correction to: Tumour draining lymph node-generated CD8 T cells play a role in controlling lung metastases after a primary tumour is removed but not when adjuvant immunotherapy is used.
Fear VS, Forbes CA, Neeve SA, Fisher SA, Chee J, Waithman J, Ma SK, Lake R, Nowak AK, Creaney J, Brown MD, Saunders C, Robinson BWS. Fear VS, et al. Among authors: robinson bws. Cancer Immunol Immunother. 2021 Nov;70(11):3259. doi: 10.1007/s00262-021-02970-z. Cancer Immunol Immunother. 2021. PMID: 34089374 Free PMC article. No abstract available.
Tumour draining lymph node-generated CD8 T cells play a role in controlling lung metastases after a primary tumour is removed but not when adjuvant immunotherapy is used.
Fear VS, Forbes CA, Neeve SA, Fisher SA, Chee J, Waithman J, Ma SK, Lake R, Nowak AK, Creaney J, Brown MD, Saunders C, Robinson BWS. Fear VS, et al. Among authors: robinson bws. Cancer Immunol Immunother. 2021 Nov;70(11):3249-3258. doi: 10.1007/s00262-021-02934-3. Epub 2021 Apr 9. Cancer Immunol Immunother. 2021. PMID: 33835222 Free PMC article.
A phase 1b clinical trial optimizing regulatory T cell depletion in combination with platinum-based chemotherapy in thoracic cancers.
Cook AM, McDonnell A, Millward MJ, Creaney J, Hasani A, McMullen M, Meniawy T, Robinson BWS, Lake RA, Nowak AK. Cook AM, et al. Among authors: robinson bws. Expert Rev Anticancer Ther. 2021 May;21(5):465-474. doi: 10.1080/14737140.2021.1882308. Epub 2021 Feb 9. Expert Rev Anticancer Ther. 2021. PMID: 33509005 Clinical Trial.
Verification of a Blood-Based Targeted Proteomics Signature for Malignant Pleural Mesothelioma.
Cerciello F, Choi M, Sinicropi-Yao SL, Lomeo K, Amann JM, Felley-Bosco E, Stahel RA, Robinson BWS, Creaney J, Pass HI, Vitek O, Carbone DP. Cerciello F, et al. Among authors: robinson bws. Cancer Epidemiol Biomarkers Prev. 2020 Oct;29(10):1973-1982. doi: 10.1158/1055-9965.EPI-20-0543. Epub 2020 Jul 30. Cancer Epidemiol Biomarkers Prev. 2020. PMID: 32732250 Free PMC article.
Tracking Neoantigens by Personalized Circulating Tumor DNA Sequencing during Checkpoint Blockade Immunotherapy in Non-Small Cell Lung Cancer.
Jia Q, Chiu L, Wu S, Bai J, Peng L, Zheng L, Zang R, Li X, Yuan B, Gao Y, Wu D, Li X, Wu L, Sun J, He J, Robinson BWS, Zhu B. Jia Q, et al. Among authors: robinson bws. Adv Sci (Weinh). 2020 Mar 26;7(9):1903410. doi: 10.1002/advs.201903410. eCollection 2020 May. Adv Sci (Weinh). 2020. PMID: 32382482 Free PMC article.
92 results